Objective To explore the different expressions of bcl-2 and vascular endothelial growth factor receptor-3 (VEGFR-3) in intravenous leiomyomatosis (IVL) and classical leiomyoma (LM).
Methods We retrospectively reviewed the pathology of 20 cases of IVL, matching with 10 cases of LM. The bcl-2 and VEGFR-3 immunohistochemical staining was performed in the slides from all cases, and the results were compared between the IVL group and LM group.
Results In the IVL group, all the 20 cases showed moderate to strong bcl-2 immunohistochemical staining. Meanwhile, 19 cases showed moderate to strong VEGFR-3 immunohistochemical staining, while 1 case was negative. In the LM group, all 10 cases showed weak to moderate bcl-2 immunohistochemical staining and negative VEGFR-3 staining.
Conclusions Both bcl-2 and VEGFR-3 are highly expressed in IVL; in particular, the expression of VEGFR-3 is dramatically different between IVL and LM. This indicates IVL and LM have different molecular alterations, which may play important roles in the pathogenesis and development of IVL.